146 related articles for article (PubMed ID: 32484414)
1. Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI: A Multicenter Study.
Joo I; Kim SY; Kang TW; Kim YK; Park BJ; Lee YJ; Choi JI; Lee CH; Park HS; Lee K; Kim H; Yu E; Kang HJ; Ha SY; Kim JY; Ahn S; Jung ES; Kim BH; Han HS; Lee JM
Radiology; 2020 Aug; 296(2):335-345. PubMed ID: 32484414
[TBL] [Abstract][Full Text] [Related]
2. Characterization of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI via contrast-enhanced ultrasound using perfluorobutane.
Bae JS; Lee JY; Suh KS; Hong SK; Yoon JH; Kim YJ; Yu SJ; Lee JH; Cho EJ; Lee YB; Han JK
Abdom Radiol (NY); 2023 Jul; 48(7):2321-2330. PubMed ID: 37097451
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic algorithm for subcentimeter hepatocellular carcinoma using alpha-fetoprotein and imaging features on gadoxetic acid-enhanced MRI.
Huang P; Wu F; Hou K; Zhou C; Xiao Y; Wang C; Miao G; Yang C; Zeng M
Eur Radiol; 2024 Apr; 34(4):2271-2282. PubMed ID: 37792079
[TBL] [Abstract][Full Text] [Related]
4. Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma.
Sun L; Mu L; Zhou J; Tang W; Zhang L; Xie S; Chen J; Wang J
Cancer Immunol Immunother; 2022 Jan; 71(1):25-38. PubMed ID: 33993366
[TBL] [Abstract][Full Text] [Related]
5. Mean ADC values and arterial phase hyperintensity discriminate small (≤ 3 cm) well-differentiated hepatocellular carcinoma from dysplastic nodule.
Zong X; Li M; Li J; Chen Q; Shi A; Gao X; Guo R
Abdom Radiol (NY); 2024 Apr; 49(4):1132-1143. PubMed ID: 38289351
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.
Van Wettere M; Paulatto L; Raynaud L; Bruno O; Payancé A; Plessier A; Rautou PE; Paradis V; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
JHEP Rep; 2020 Jun; 2(3):100097. PubMed ID: 32435753
[TBL] [Abstract][Full Text] [Related]
7. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with serum markers in at-risk patients with hepatitis B virus.
Han D; Li Y; He X; Zhang J; Zhou Y; Zhang J; Zhang L
Quant Imaging Med Surg; 2023 Oct; 13(10):7156-7169. PubMed ID: 37869332
[TBL] [Abstract][Full Text] [Related]
8. Detection of arterial phase hyperenhancement of small hepatocellular carcinoma with MRI: Comparison between single arterial and multi-arterial phases and between extracellular and hepatospecific contrast agents.
Bouyer T; Roux M; Jacquemin S; Dioguardi Burgio M; Sutter O; Laurent-Croisé V; Lonjon J; Bricault I; Trillaud H; Rode A; Aubé C; Paisant A
Diagn Interv Imaging; 2023 Oct; 104(10):477-484. PubMed ID: 37211446
[TBL] [Abstract][Full Text] [Related]
9. Gadoxetic Acid-Enhanced Liver MRI: Everything You Need to Know.
Ichikawa S; Goshima S
Invest Radiol; 2024 Jan; 59(1):53-68. PubMed ID: 37227150
[TBL] [Abstract][Full Text] [Related]
10. Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5
Auer TA; Halskov S; Fehrenbach U; Nevermann NF; Pelzer U; Mohr R; Hamm B; Schöning W; Horst D; Ihlow J; Geisel D
Eur Radiol; 2023 Oct; 33(10):6902-6915. PubMed ID: 37115216
[TBL] [Abstract][Full Text] [Related]
11. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study.
Ding F; Huang M; Ren P; Zhang J; Lin Z; Sun Y; Liang C; Zhao X
Eur Radiol; 2024 Apr; 34(4):2445-2456. PubMed ID: 37691080
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal hepatobiliary phase image in gadoxetic acid-enhanced liver MRI for the evaluation of the HCC: Predictive factors.
Ryeom H; Chang Y; Park SY; Cho SH; Yeo B; Je H; Baek J
Medicine (Baltimore); 2023 Nov; 102(46):e36176. PubMed ID: 37986292
[TBL] [Abstract][Full Text] [Related]
13. Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment.
Jeon SK; Lee DH; Hur BY; Park SJ; Kim SW; Park J; Suh KS; Lee KW; Yi NJ; Han JK
J Magn Reson Imaging; 2023 Nov; 58(5):1375-1383. PubMed ID: 36825827
[TBL] [Abstract][Full Text] [Related]
14. Can absolute arterial phase hyperenhancement improve sensitivity of detection of hepatocellular carcinoma in indeterminate nodules on CT?
Zafar S; Elbanna KY; Todd AWM; Guimaraes L; O'Brien C; Goel A; Kim TK; Khalili K
Eur Radiol; 2024 Apr; 34(4):2256-2268. PubMed ID: 37775590
[TBL] [Abstract][Full Text] [Related]
15. Multicenter Validation of Abbreviated MRI for Detecting Early-Stage Hepatocellular Carcinoma.
Yokoo T; Masaki N; Parikh ND; Lane BF; Feng Z; Mendiratta-Lala M; Lee CH; Khatri G; Marsh TL; Shetty K; Dunn CT; Al-Jarrah T; Aslam A; Davenport MS; Gopal P; Rich NE; Lok AS; Singal AG
Radiology; 2023 Apr; 307(2):e220917. PubMed ID: 36692401
[TBL] [Abstract][Full Text] [Related]
16. Application of a deep learning algorithm for three-dimensional T1-weighted gradient-echo imaging of gadoxetic acid-enhanced MRI in patients at a high risk of hepatocellular carcinoma.
Kim JH; Yoon JH; Kim SW; Park J; Bae SH; Lee JM
Abdom Radiol (NY); 2024 Mar; 49(3):738-747. PubMed ID: 38095685
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of the gadoxetic acid MRI-derived relative enhancement index (REI) and functional liver imaging score (FLIS) in predicting liver function: validation with Albumin-Bilirubin (ALBI) grade.
Eryuruk U; Tasdemir MN; Karasu HI; Aslan S
Abdom Radiol (NY); 2024 May; 49(5):1456-1466. PubMed ID: 38653813
[TBL] [Abstract][Full Text] [Related]
18. MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.
García-Criado Á; Rimola J; Seijo S; Darnell A; Belmonte E; Sapena V; Moreno-Rojas J; Pérez V; Hernández-Gea V; Ayuso C; Reig M; García-Pagán JC; Bruix J
Liver Cancer; 2024 Apr; 13(2):203-214. PubMed ID: 38751551
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the Performance of Gadoxetic Acid Disodium MRI in Predicting Microvascular Invasion of Hepatocellular Carcinoma.
Chen J; Ming X; Wang Z; Ye Y
Contrast Media Mol Imaging; 2022; 2022():6128845. PubMed ID: 36247863
[TBL] [Abstract][Full Text] [Related]
20. HCCs lacking arterial phase hyperenhancement (APHE) on contrast-enhanced ultrasound (CEUS) - a diagnostic challenge. Findings from the prospective multicenter DEGUM CEUS HCC trial.
Strobel D; Agaimy A; Jesper D; Zundler S; Schellhaas B
Ultraschall Med; 2023 Dec; 44(6):606-613. PubMed ID: 36781161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]